Published • loading... • Updated
J&J Stock at All-Time High as UBS Assumes at Buy (JNJ:NYSE)
Summary by Seeking Alpha
6 Articles
6 Articles
UBS rises the target price of the J&J from US$ 280 to US$ 320 and indicates that stock rally in historical peaks has breath
Johnson & Johnson Shares Jump Toward the Record High After FDA Approval; UBS Lifts Target to $320
Johnson & Johnson's stock reached a record high following FDA approval of its drug Imaavy and a positive sales forecast, despite ongoing legal challenges and market pressures.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
